R/R HR-MDS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) (NCT07384715) | Genmab | 2026-02-16 |
Track R/R HR-MDS automatically
Every clearance here is in the API, with alerts when new ones post.